{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:14:39Z","timestamp":1760242479195,"version":"build-2065373602"},"reference-count":64,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:00:00Z","timestamp":1505174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is an \u201cumbrella\u201d definition that encompasses a spectrum of histological liver changes ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) with\/without fibrosis, \u201ccryptogenic\u201d cirrhosis, and hepatocellular carcinoma (HCC), occurring in a dysmetabolic milieu, though in the absence of excessive alcohol consumption and other competing etiologies of chronic liver disease [1].[...]<\/jats:p>","DOI":"10.3390\/ijms18091955","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T10:40:04Z","timestamp":1505212804000},"page":"1955","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["NAFLD: Is There Anything New under the Sun?"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9886-0698","authenticated-orcid":false,"given":"Amedeo","family":"Lonardo","sequence":"first","affiliation":[{"name":"Division of Internal Medicine, Department of Biomedical, Metabolic and Neural Sciences, Azienda Ospedaliero-Universitaria, Ospedale Civile di Baggiovara, 41125 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-3900","authenticated-orcid":false,"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, 37126 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2017,9,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Italian Association for the Study of the Liver (AISF) (2017). AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. Dig. Liver Dis., 49, 471\u2013483.","DOI":"10.1016\/j.dld.2017.01.147"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"Ballestri","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/hepr.12656","article-title":"The independent predictors of non-alcoholic steatohepatitis and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment","volume":"46","author":"Ballestri","year":"2016","journal-title":"Hepatol. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1586\/egh.11.24","article-title":"Perspectives on cellular dysfunction in nonalcoholic steatohepatitis: A case of \u201cmultiorganelle failure\u201d? Proceedings of a virtual workshop on nonalcoholic steatohepatitis","volume":"5","author":"Lonardo","year":"2011","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrgastro.2013.34","article-title":"NAFLD in Asia\u2014As common and important as in the West","volume":"10","author":"Farrell","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dld.2015.08.004","article-title":"Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2016). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"25552","DOI":"10.3390\/ijms161025552","article-title":"Non-alcoholic steatohepatitis (NASH): Risk factors in morbidly obese patients","volume":"16","author":"Losekann","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lombardi, R., Pisano, G., and Fargion, S. (2016). Role of serum uric acid and ferritin in the development and progression of NAFLD. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17040548"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"28014","DOI":"10.3390\/ijms161226085","article-title":"Does Lysosomial acid lipase reduction play a role in adult non-alcoholic fatty liver disease?","volume":"16","author":"Baratta","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Shteyer, E., Villenchik, R., Mahamid, M., Nator, N., and Safadi, R. (2016). Low serum lysosomal acid lipase activity correlates with advanced liver disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030312"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Brunt, E. (2016). Nonalcoholic fatty liver disease: Pros and cons of histologic systems of evaluation. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17010097"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kirchner, H., Shaheen, F., Kalscheuer, H., Schmid, S.M., Oster, H., and Lehnert, H. (2017). The telomeric complex and metabolic disease. Genes, 8.","DOI":"10.3390\/genes8070176"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.gene.2016.08.017","article-title":"Aneuploidy and asynchronous replication in non-alcoholic fatty liver disease and cryptogenic cirrhosis","volume":"593","author":"Laish","year":"2016","journal-title":"Gene"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Donati, B., and Valenti, L. (2016). Telomeres NAFLD and chronic liver disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030383"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ban, L., Shackel, N., and McLennan, S. (2016). Extracellular vesicles: A new frontier in biomarker discovery for non-alcoholic fatty liver disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030376"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Nu\u00f1o-L\u00e1mbarri, N., Barbero-Becerra, V., Uribe, M., and Ch\u00e1vez-Tapia, N. (2016). Mitochondrial molecular pathophysiology of nonalcoholic fatty liver disease: A proteomics approach. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030281"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Gambino, R., Bugianesi, E., Rosso, C., Mezzabotta, L., Pinach, S., Alemanno, N., Saba, F., and Cassader, M. (2016). Different serum free fatty acid profiles in NAFLD subjects and healthy controls after oral fat load. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17040479"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Houghton, D., Stewart, C., Day, C., and Trenell, M. (2016). Gut microbiota and lifestyle interventions in NAFLD. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17040447"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Machado, M., and Cortez-Pinto, H. (2016). Diet microbiota obesity and NAFLD: A dangerous quartet. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17040481"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Aragon\u00e8s, G., Auguet, T., Armengol, S., Berlanga, A., Guiu-Jurado, E., Aguilar, C., Mart\u00ednez, S., Sabench, F., Porras, J., and Ruiz, M. (2016). PNPLA3 expression is related to liver steatosis in morbidly obese women with non-alcoholic fatty liver disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050630"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Pet\u00e4j\u00e4, E., and Yki-J\u00e4rvinen, H. (2016). Definitions of normal liver fat and the association of insulin sensitivity with acquired and genetic NAFLD\u2014A systematic review. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050633"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.atherosclerosis.2017.01.008","article-title":"\u201cNot all forms of NAFLD were created equal\u201d. Do metabolic syndrome-related NAFLD and PNPLA3-related NAFLD exert a variable impact on the risk of early carotid atherosclerosis?","volume":"257","author":"Lonardo","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Pisano, G., Lombardi, R., and Fracanzani, A. (2016). Vascular damage in patients with nonalcoholic fatty liver disease: Possible role of iron and ferritin. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050675"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Verdelho Machado, M., and Diehl, A. (2016). Role of hedgehog signaling pathway in NASH. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17060857"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Caligiuri, A., Gentilini, A., and Marra, F. (2016). Molecular pathogenesis of NASH. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091575"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"France, M., Kwok, S., Soran, H., Williams, S., Ho, J., Adam, S., Canoy, D., Liu, Y., and Durrington, P. (2016). Liver fat measured by MR spectroscopy: Estimate of imprecision and relationship with serum glycerol, caeruloplasmin and non-esterified fatty acids. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17071089"},{"key":"ref_33","first-page":"2072","article-title":"Nonalcoholic steatohepatitis and the \u201cbright liver syndrome\u201d: Should a recently expanded clinical entity be further expanded?","volume":"90","author":"Lonardo","year":"1995","journal-title":"Am. J. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: A multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.dld.2015.10.027","article-title":"A \u201csystems medicine\u201d approach to the study of non-alcoholic fatty liver disease","volume":"48","author":"Petta","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrneph.2017.16","article-title":"Non-alcoholic fatty liver disease: An emerging driving force in chronic kidney disease","volume":"13","author":"Targher","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1590-8658(01)80144-4","article-title":"Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI. ST. ENA study","volume":"33","author":"Lonardo","year":"2001","journal-title":"Dig. Liver Dis."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mantovani, A., Gisondi, P., Lonardo, A., and Targher, G. (2016). Relationship between non-alcoholic fatty liver disease and psoriasis: A novel hepato-dermal axis?. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17020217"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Wainwright, P., and Byrne, C. (2016). Bidirectional relationships and disconnects between NAFLD and features of the metabolic syndrome. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030367"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ballestri, S., Nascimbeni, F., Romagnoli, D., Baldelli, E., Targher, G., and Lonardo, A. (2016). Type 2 Diabetes in non-alcoholic fatty liver disease and hepatitis C virus infection\u2014Liver: The \u201cMusketeer\u201d in the spotlight. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030355"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Perticone, M., Cimellaro, A., Maio, R., Caroleo, B., Sciacqua, A., Sesti, G., and Perticone, F. (2016). Additive effect of non-alcoholic fatty liver disease on metabolic syndrome-related endothelial dysfunction in hypertensive patients. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17040456"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Marcuccilli, M., and Chonchol, M. (2016). NAFLD and chronic kidney disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17040562"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Villela-Nogueira, C., Leite, N., Cardoso, C., and Salles, G. (2016). NAFLD and increased aortic stiffness: Parallel or common physiopathological mechanisms?. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17040460"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sanna, C., Rosso, C., Marietti, M., and Bugianesi, E. (2016). Non-alcoholic fatty liver disease and extra-hepatic cancers. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050717"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12325-016-0306-9","article-title":"The role of nuclear receptors in the pathophysiology, natural course, and drug treatment of NAFLD in humans","volume":"33","author":"Ballestri","year":"2016","journal-title":"Adv. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.2174\/1381612811319290003","article-title":"Cardiovascular and systemic risk in nonalcoholic fatty liver disease\u2014Atherosclerosis as a major player in the natural course of NAFLD","volume":"19","author":"Lonardo","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Calzadilla Bertot, L., and Adams, L. (2016). The natural course of non-alcoholic fatty liver disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050774"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Gitto, S., and Villa, E. (2016). Non-alcoholic fatty liver disease and metabolic syndrome after liver transplant. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17040490"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.metabol.2016.01.008","article-title":"Similarities and differences between pediatric and adult nonalcoholic fatty liver disease","volume":"65","author":"Crespo","year":"2016","journal-title":"Metabolism"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Temple, J., Cordero, P., Li, J., Nguyen, V., and Oben, J. (2016). A Guide to non-alcoholic fatty liver disease in childhood and adolescence. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17060947"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Pacifico, L., Bonci, E., Andreoli, G., di Martino, M., Gallozzi, A., De Luca, E., and Chiesa, C. (2016). The impact of nonalcoholic fatty liver disease on renal function in children with overweight\/obesity. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17081218"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","article-title":"Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease","volume":"126","author":"Lonardo","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jhep.2007.01.021","article-title":"Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C","volume":"46","author":"Targher","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.3748\/wjg.v20.i23.7089","article-title":"Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen","volume":"20","author":"Lonardo","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3748\/wjg.v23.i8.1458","article-title":"Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis","volume":"23","author":"Rinaldi","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Adinolfi, L., Rinaldi, L., Guerrera, B., Restivo, L., Marrone, A., Giordano, M., and Zampino, R. (2016). NAFLD and NASH in HCV infection: Prevalence and significance in hepatic and extrahepatic manifestations. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17060803"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Shigefuku, R., Takahashi, H., Nakano, H., Watanabe, T., Matsunaga, K., Matsumoto, N., Kato, M., Morita, R., Michikawa, Y., and Tamura, T. (2016). Correlations of hepatic hemodynamics liver function and fibrosis markers in nonalcoholic fatty liver disease: Comparison with chronic hepatitis related to hepatitis C virus. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091545"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/17474124.2015.965143","article-title":"Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease","volume":"9","author":"Lonardo","year":"2015","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Stachowska, E., Ryterska, K., Maciejewska, D., Banaszczak, M., Milkiewicz, P., Milkiewicz, M., Gutowska, I., Ossowski, P., Kaczorowska, M., and Jamio\u0142-Milc, D. (2016). Nutritional strategies for the individualized treatment of non-alcoholic fatty liver disease (NAFLD) based on the nutrient-induced insulin output ratio (NIOR). Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17071192"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"25168","DOI":"10.3390\/ijms161025168","article-title":"Relevant aspects of nutritional and dietary interventions in non-alcoholic fatty liver disease","volume":"16","author":"Valenzuela","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"21056","DOI":"10.3390\/ijms160921056","article-title":"Weekly treatment of 2-hydroxypropyl-\u03b2-cyclodextrin improves intracellular cholesterol levels in LDL receptor knockout mice","volume":"1","author":"Walenbergh","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"29207","DOI":"10.3390\/ijms161226156","article-title":"The DIPEPTIDYL peptidase-4 Inhibitor teneligliptin attenuates hepatic lipogenesis via AMPK activation in non-alcoholic fatty liver disease model mice","volume":"16","author":"Ideta","year":"2015","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/9\/1955\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:44:43Z","timestamp":1760208283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/9\/1955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,12]]},"references-count":64,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9]]}},"alternative-id":["ijms18091955"],"URL":"https:\/\/doi.org\/10.3390\/ijms18091955","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2017,9,12]]}}}